Guardant Health (GH) EBITDA (2017 - 2025)
Historic EBITDA for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$99.0 million.
- Guardant Health's EBITDA rose 1563.05% to -$99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$442.4 million, marking a year-over-year increase of 1411.89%. This contributed to the annual value of -$443.6 million for FY2024, which is 2144.96% up from last year.
- Latest data reveals that Guardant Health reported EBITDA of -$99.0 million as of Q3 2025, which was up 1563.05% from -$106.4 million recorded in Q2 2025.
- Over the past 5 years, Guardant Health's EBITDA peaked at -$97.6 million during Q2 2021, and registered a low of -$197.5 million during Q4 2023.
- Its 5-year average for EBITDA is -$120.0 million, with a median of -$113.5 million in 2023.
- In the last 5 years, Guardant Health's EBITDA crashed by 20895.68% in 2021 and then skyrocketed by 3622.38% in 2024.
- Quarter analysis of 5 years shows Guardant Health's EBITDA stood at -$98.2 million in 2021, then crashed by 48.79% to -$146.1 million in 2022, then plummeted by 35.17% to -$197.5 million in 2023, then skyrocketed by 36.22% to -$126.0 million in 2024, then increased by 21.42% to -$99.0 million in 2025.
- Its last three reported values are -$99.0 million in Q3 2025, -$106.4 million for Q2 2025, and -$111.0 million during Q1 2025.